Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2019

Open Access 01-08-2019 | Addiction | Research Article

The appropriateness of psychotropic medicines: an interview study of service users attending a substance misuse service in England

Authors: Adejoke Obirenjeyi Oluyase, Duncan Raistrick, Elizabeth Hughes, Charlie Lloyd

Published in: International Journal of Clinical Pharmacy | Issue 4/2019

Login to get access

Abstract

Background Mental health problems are common in people with substance misuse problems. However, there is a paucity of evidence regarding prescribing of psychotropic medications for people with comorbid mental health and substance misuse problems. Objective To explore the views of service users attending an addiction service on the appropriateness of psychotropic medications prescribed for their co-existing mental health problems. Setting A specialist addiction service in the North of England. Method A phenomenological approach was adopted. Semi-structured interviews were conducted with twelve service users. Data were analysed using thematic framework analysis. Main outcome measure Service users’ views concerning the appropriateness of their prescribed psychotropic medications. Results The following themes captured service users’ views on the appropriateness of their medications: benefits from medicines, entitlement to medicines, and assessment and review. Service users mostly described benefits from their medications (including those prescribed outside guideline recommendations) and there was also an awareness of the adverse effects they experienced from them. It appears that people with substance misuse problems have a particularly strong sense of their own needs and seek to influence prescribing decisions. Service users further described varied practices regarding assessment and review of their medications with evidence of regular reviews while others identified suboptimal or inadequate practices. Conclusion Most service users described improved functioning as a result of their prescribed psychotropic medications. Prescriptions that are inappropriate in terms of their usual indications may well be justified if they assist in stabilising service users and moving them on to recovery.
Literature
1.
go back to reference Lexchin J. Improving the appropriateness of physician prescribing. Int J Health Serv. 1998;28(2):253–67.CrossRef Lexchin J. Improving the appropriateness of physician prescribing. Int J Health Serv. 1998;28(2):253–67.CrossRef
2.
go back to reference Cribb A, Barber N. Prescribers, patients and policy: the limits of technique. Health Care Anal. 1997;5(4):292–8.CrossRef Cribb A, Barber N. Prescribers, patients and policy: the limits of technique. Health Care Anal. 1997;5(4):292–8.CrossRef
3.
go back to reference Barber N, Bradley C, Barry C, Stevenson F, Britten N, Jenkins L. Measuring the appropriateness of prescribing in primary care: are current measures complete? J Clin Pharm Ther. 2005;30(6):533–9.CrossRef Barber N, Bradley C, Barry C, Stevenson F, Britten N, Jenkins L. Measuring the appropriateness of prescribing in primary care: are current measures complete? J Clin Pharm Ther. 2005;30(6):533–9.CrossRef
4.
go back to reference World Health Organisation. Global status report on alcohol and health 2018. WHO; 2018. World Health Organisation. Global status report on alcohol and health 2018. WHO; 2018.
5.
go back to reference Lozano OM, Rojas AJ, Fernandez Calderon F. Psychiatric comorbidity and severity of dependence on substance users: How it impacts on their health-related quality of life? J Ment Health. 2017;26(2):119–26.CrossRef Lozano OM, Rojas AJ, Fernandez Calderon F. Psychiatric comorbidity and severity of dependence on substance users: How it impacts on their health-related quality of life? J Ment Health. 2017;26(2):119–26.CrossRef
6.
go back to reference Tucker JA, Simpson CA. The recovery spectrum: from self-change to seeking treatment. Alcohol Res Health. 2011;33(4):371–9.PubMedPubMedCentral Tucker JA, Simpson CA. The recovery spectrum: from self-change to seeking treatment. Alcohol Res Health. 2011;33(4):371–9.PubMedPubMedCentral
7.
go back to reference Oluyase AO, Raistrick D, Hughes E, Lloyd C. Prescribers’ views and experiences of assessing the appropriateness of prescribed medications in a specialist addiction service. Int J Clin Pharm. 2017;39(6):1248–55.CrossRef Oluyase AO, Raistrick D, Hughes E, Lloyd C. Prescribers’ views and experiences of assessing the appropriateness of prescribed medications in a specialist addiction service. Int J Clin Pharm. 2017;39(6):1248–55.CrossRef
8.
go back to reference Hughes E. Guidelines for working with mental health-substance use. In: Cooper DB, editor. Developing services in mental health-substance use. Bloomberg: Radcliffe Publishing Ltd; 2011. Hughes E. Guidelines for working with mental health-substance use. In: Cooper DB, editor. Developing services in mental health-substance use. Bloomberg: Radcliffe Publishing Ltd; 2011.
10.
go back to reference National Institute for Health and Care Excellence. Coexisting severe mental illness and substance misuse: community health and social care services. London: NICE; 2016. National Institute for Health and Care Excellence. Coexisting severe mental illness and substance misuse: community health and social care services. London: NICE; 2016.
11.
go back to reference Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRef
12.
go back to reference Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care QHC. 1998;7(3):130–5.CrossRef Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care QHC. 1998;7(3):130–5.CrossRef
13.
go back to reference Edlund MJ, Harris KM. Perceived effectiveness of medications among mental health service users with and without alcohol dependence. Psychiatr Serv. 2006;57(5):692–9.CrossRef Edlund MJ, Harris KM. Perceived effectiveness of medications among mental health service users with and without alcohol dependence. Psychiatr Serv. 2006;57(5):692–9.CrossRef
14.
go back to reference Foulds JA, Rouch S, Spence J, Mulder RT, Sellman JD. Prescribed psychotropic medication use in patients receiving residential addiction treatment. Alcohol Alcohol. 2016;51(5):622–3.CrossRef Foulds JA, Rouch S, Spence J, Mulder RT, Sellman JD. Prescribed psychotropic medication use in patients receiving residential addiction treatment. Alcohol Alcohol. 2016;51(5):622–3.CrossRef
15.
go back to reference Foulds JA, Lubman DI. Treating depression in patients with alcohol or drug use disorders: a need for clearer guidelines. ANZJP. 2017;51(7):668–9.CrossRef Foulds JA, Lubman DI. Treating depression in patients with alcohol or drug use disorders: a need for clearer guidelines. ANZJP. 2017;51(7):668–9.CrossRef
16.
go back to reference Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. J Clin Psychopharmacol. 2011;31(5):582–6.CrossRef Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. J Clin Psychopharmacol. 2011;31(5):582–6.CrossRef
17.
go back to reference Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord. 2015;185:47–59.CrossRef Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord. 2015;185:47–59.CrossRef
18.
go back to reference Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2013;28(1):7–20.CrossRef Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2013;28(1):7–20.CrossRef
20.
go back to reference Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345(8953):840–2.CrossRef Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345(8953):840–2.CrossRef
23.
go back to reference Health and Social Care Act 2012. London: Stationery Office. Health and Social Care Act 2012. London: Stationery Office.
24.
go back to reference National Institute for Health and Care Excellence. Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. London: NICE; 2012. National Institute for Health and Care Excellence. Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. London: NICE; 2012.
25.
go back to reference Joosten EA, De Jong CA, de Weert-van Oene GH, Sensky T, van der Staak CP. Shared decision-making: increases autonomy in substance-dependent patients. Subst Use Misuse. 2011;46(8):1037–8.CrossRef Joosten EA, De Jong CA, de Weert-van Oene GH, Sensky T, van der Staak CP. Shared decision-making: increases autonomy in substance-dependent patients. Subst Use Misuse. 2011;46(8):1037–8.CrossRef
26.
go back to reference Friedrichs A, Spies M, Harter M, Buchholz A. Patient preferences and shared decision making in the treatment of substance use disorders: a systematic review of the literature. PLoS ONE. 2016;11(1):e0145817.CrossRef Friedrichs A, Spies M, Harter M, Buchholz A. Patient preferences and shared decision making in the treatment of substance use disorders: a systematic review of the literature. PLoS ONE. 2016;11(1):e0145817.CrossRef
27.
go back to reference McCallum SL, Mikocka-Walus AA, Gaughwin MD, Andrews JM, Turnbull DA. ‘I’m a sick person, not a bad person’: patient experiences of treatments for alcohol use disorders. Health Expect. 2016;19(4):828–41.CrossRef McCallum SL, Mikocka-Walus AA, Gaughwin MD, Andrews JM, Turnbull DA. ‘I’m a sick person, not a bad person’: patient experiences of treatments for alcohol use disorders. Health Expect. 2016;19(4):828–41.CrossRef
28.
go back to reference Gallagher S. What is phenomenology? Phenomenology palgrave philosophy today. London: Palgrave Macmillan; 2012. Gallagher S. What is phenomenology? Phenomenology palgrave philosophy today. London: Palgrave Macmillan; 2012.
30.
go back to reference Oluyase AO. A study of the appropriateness of prescriptions for mental health disorders or pain among users of a specialist treatment service for substance use disorders. York: University of York; 2015. Oluyase AO. A study of the appropriateness of prescriptions for mental health disorders or pain among users of a specialist treatment service for substance use disorders. York: University of York; 2015.
31.
go back to reference Marshall MN. Sampling for qualitative research. Family Pract. 1996;13(6):522–5.CrossRef Marshall MN. Sampling for qualitative research. Family Pract. 1996;13(6):522–5.CrossRef
32.
go back to reference Robinson OC. Sampling in interview-based qualitative research: a theoretical and practical guide. Qual Res Psychol. 2014;11(1):25–41.CrossRef Robinson OC. Sampling in interview-based qualitative research: a theoretical and practical guide. Qual Res Psychol. 2014;11(1):25–41.CrossRef
33.
go back to reference Miles MB, Huberman AM. Qualitative data analysis: a sourcebook of new methods. Beverly Hills: Sage Publications; 1994. Miles MB, Huberman AM. Qualitative data analysis: a sourcebook of new methods. Beverly Hills: Sage Publications; 1994.
34.
go back to reference Ali SI, Ajmal SR. When is off-label prescribing appropriate? Curr Psychiatry. 2012;11(7):23–7. Ali SI, Ajmal SR. When is off-label prescribing appropriate? Curr Psychiatry. 2012;11(7):23–7.
35.
go back to reference Sugarman P, Mitchell A, Frogley C, Dickens GL, Picchioni M. Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance. Ther Adv Psychopharmacol. 2013;3(4):233–43.CrossRef Sugarman P, Mitchell A, Frogley C, Dickens GL, Picchioni M. Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance. Ther Adv Psychopharmacol. 2013;3(4):233–43.CrossRef
36.
go back to reference Sutherland A, Waldek S. It is time to review how unlicensed medicines are used. Eur J Clin Pharmacol. 2015;71(9):1029–35.CrossRef Sutherland A, Waldek S. It is time to review how unlicensed medicines are used. Eur J Clin Pharmacol. 2015;71(9):1029–35.CrossRef
37.
go back to reference Tucker JA, Roth DL. Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders. Addiction. 2006;101(7):918–32.CrossRef Tucker JA, Roth DL. Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders. Addiction. 2006;101(7):918–32.CrossRef
38.
go back to reference Spieth PM, Kubasch AS, Penzlin AI, Illigens BMW, Barlinn K, Siepmann T. Randomized controlled trials—a matter of design. Neuropsychiatr Dis Treat. 2016;12:1341–9.PubMedPubMedCentral Spieth PM, Kubasch AS, Penzlin AI, Illigens BMW, Barlinn K, Siepmann T. Randomized controlled trials—a matter of design. Neuropsychiatr Dis Treat. 2016;12:1341–9.PubMedPubMedCentral
39.
go back to reference Geleris P, Boudoulas H. Problems related to the application of guidelines in clinical practice: a critical analysis. Hell J Cardiol. 2011;52(2):97–102. Geleris P, Boudoulas H. Problems related to the application of guidelines in clinical practice: a critical analysis. Hell J Cardiol. 2011;52(2):97–102.
40.
go back to reference Ostacher MJ. Bipolar and substance use disorder comorbidity: diagnostic and treatment considerations. FOCUS. 2011;9(4):428–34.CrossRef Ostacher MJ. Bipolar and substance use disorder comorbidity: diagnostic and treatment considerations. FOCUS. 2011;9(4):428–34.CrossRef
41.
go back to reference Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012;25(3):194–200.CrossRef Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012;25(3):194–200.CrossRef
42.
go back to reference Gershwin EM, Hamilton ME. The pain management handbook. A concise guide to diagnosis and treatment. New Jersey: Humana Press Inc; 1998. Gershwin EM, Hamilton ME. The pain management handbook. A concise guide to diagnosis and treatment. New Jersey: Humana Press Inc; 1998.
43.
go back to reference Royal College of Psychiatrists. Consensus statement on high-dose antipsychotic medication. College Report CR190. 2014. Royal College of Psychiatrists. Consensus statement on high-dose antipsychotic medication. College Report CR190. 2014.
44.
go back to reference Action on Addiction. The management of pain in people with a past or current history of addiction. London: Action on Addiction; 2013. Action on Addiction. The management of pain in people with a past or current history of addiction. London: Action on Addiction; 2013.
45.
46.
go back to reference Foot C, Gilburt H, Dunn P, Jabbal J, Seale B, Goodrich J, et al. People in control of their own health and care: the state of involvement. London: The King’s Fund; 2014. Foot C, Gilburt H, Dunn P, Jabbal J, Seale B, Goodrich J, et al. People in control of their own health and care: the state of involvement. London: The King’s Fund; 2014.
47.
go back to reference Vadivelu N, Lumermann L, Zhu R, Kodumudi G, Elhassan AO, Kaye AD. Pain control in the presence of drug addiction. Curr Pain Headache Rep. 2016;20(5):35.CrossRef Vadivelu N, Lumermann L, Zhu R, Kodumudi G, Elhassan AO, Kaye AD. Pain control in the presence of drug addiction. Curr Pain Headache Rep. 2016;20(5):35.CrossRef
48.
go back to reference Bond C, Blenkinsopp A, Raynor DK. Prescribing and partnership with patients. Br J Clin Pharmacol. 2012;74(4):581–8.CrossRef Bond C, Blenkinsopp A, Raynor DK. Prescribing and partnership with patients. Br J Clin Pharmacol. 2012;74(4):581–8.CrossRef
49.
go back to reference Waller D. The science of prescribing. Br J Clin Pharmacol. 2012;74(4):559–60.CrossRef Waller D. The science of prescribing. Br J Clin Pharmacol. 2012;74(4):559–60.CrossRef
50.
go back to reference Britten N. Patients’ demands for prescriptions in primary care. BMJ. 1995;310(6987):1084–5.CrossRef Britten N. Patients’ demands for prescriptions in primary care. BMJ. 1995;310(6987):1084–5.CrossRef
51.
go back to reference McKenna HP, Ashton S, Keeney S. Barriers to evidence-based practice in primary care. J Adv Nurs. 2004;45(2):178–89.CrossRef McKenna HP, Ashton S, Keeney S. Barriers to evidence-based practice in primary care. J Adv Nurs. 2004;45(2):178–89.CrossRef
53.
go back to reference Durà-Vilà G, Littlewood R, Leavey G. Depression and the medicalization of sadness: conceptualization and recommended help-seeking. Int J Soc Psychiatry. 2013;59(2):165–75.CrossRef Durà-Vilà G, Littlewood R, Leavey G. Depression and the medicalization of sadness: conceptualization and recommended help-seeking. Int J Soc Psychiatry. 2013;59(2):165–75.CrossRef
54.
go back to reference Whitesell M, Bachand A, Peel J, Brown M. Familial, social, and individual factors contributing to risk for adolescent substance use. J Addict. 2013;2013:9.CrossRef Whitesell M, Bachand A, Peel J, Brown M. Familial, social, and individual factors contributing to risk for adolescent substance use. J Addict. 2013;2013:9.CrossRef
55.
go back to reference Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013;28:388–406.CrossRef Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013;28:388–406.CrossRef
56.
go back to reference Samokhvalov AV, Awan S, George TP, Irving J, Le Foll B, Perrotta S, et al. Integrated care pathway for co-occurring major depressive and alcohol use disorders: outcomes of the first two years. Am J Addict. 2017;26(6):602–9.CrossRef Samokhvalov AV, Awan S, George TP, Irving J, Le Foll B, Perrotta S, et al. Integrated care pathway for co-occurring major depressive and alcohol use disorders: outcomes of the first two years. Am J Addict. 2017;26(6):602–9.CrossRef
57.
go back to reference England NHS. Electronic repeat dispensing. London: Patients & Information NHS England; 2015. England NHS. Electronic repeat dispensing. London: Patients & Information NHS England; 2015.
58.
go back to reference NHS Employers. Guidance for the implementation of repeat dispensing. London: NHS Employers; 2013. NHS Employers. Guidance for the implementation of repeat dispensing. London: NHS Employers; 2013.
59.
go back to reference Petty D. Repeat prescription report. Pharmacy2U; 2017. Petty D. Repeat prescription report. Pharmacy2U; 2017.
60.
go back to reference Wilson PM, Kataria N, McNeilly E. Patient and carer experience of obtaining regular prescribed medication for chronic disease in the English National Health Service: a qualitative study. BMC Health Serv Res. 2013;13:192.CrossRef Wilson PM, Kataria N, McNeilly E. Patient and carer experience of obtaining regular prescribed medication for chronic disease in the English National Health Service: a qualitative study. BMC Health Serv Res. 2013;13:192.CrossRef
61.
go back to reference Saastamoinen L, Enlund H, Klaukka T. Repeat prescribing in primary care: a prescription study. Pharm World Sci. 2008;30(5):605–9.CrossRef Saastamoinen L, Enlund H, Klaukka T. Repeat prescribing in primary care: a prescription study. Pharm World Sci. 2008;30(5):605–9.CrossRef
Metadata
Title
The appropriateness of psychotropic medicines: an interview study of service users attending a substance misuse service in England
Authors
Adejoke Obirenjeyi Oluyase
Duncan Raistrick
Elizabeth Hughes
Charlie Lloyd
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00861-z

Other articles of this Issue 4/2019

International Journal of Clinical Pharmacy 4/2019 Go to the issue